. "Appendix E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases." Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press, 2006.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Summary
Implementation Dates
Trials initiated on or after July 1, 2005, and meeting the above requirements should be included in a clinical trial registry.
Ongoing clinical trials meeting the above requirements should be included in a clinical trial registry by September 13, 2005.
With respect to the posting of clinical trial results, this proposal applies to clinical trials meeting the above requirements that have been completed since the publication date of this joint position statement.
Compliance
Companies subscribing to the joint position should establish a process of verification for both the clinical trial registry and the clinical trial database. Companies are encouraged to make public how they will adhere to these standards.
